Taneptacogin alfa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTaneptacogin alfa

Drug Alias NameASISFFR-VIIaFFR-FVIIaActive Site Inhibited SevenActive Site Inactivated Seven

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor

Mechanisms of ActionCoagulation factor VII inhibitors

TargetsCoagulation factor VII

Therapy Area/IndicationsVascular restenosisThrombosisCoronary Restenosis +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovo Nordisk A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNovo Nordisk A/S

Active IndicationsN/A

Inactive IndicationsVascular restenosisThrombosisCoronary Restenosis +[4]

ATC CodeN/A